Avecho Biotechnology Archives | Cannabiz

News in brief: Avecho appoints new CFO, reports cash decline; NTI answers ASX funding questions; CCA names new policy advisor

by Adam Sheldon October 26, 2026October 29, 2026

Avecho Biotechnology has appointed Subaraj Subramaniam as its new chief financial officer, replacing Melanie Leydin, who […]

News in brief: Cannaponics acquisition; Avecho share volatility; sluggish TCann crowdfund raise

by Steve Jones October 22, 2026October 22, 2026

End in sight for Avecho as Phase III CBD trial moves into final stage

by Adam Sheldon August 31, 2026August 31, 2026

Avecho recruits biotech exec to drive CBD global licensing push

by Adam Sheldon August 24, 2026August 27, 2026

Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites

by Steve Jones July 29, 2026July 30, 2026

Wait for CBD analysis was ‘torture’, says Avecho CEO as talks resume over licencing deals

by Steve Jones July 9, 2026July 9, 2026

Avecho breathes ‘huge sigh of relief’ as early data points to successful CBD insomnia trial

by Steve Jones June 24, 2026June 25, 2026

News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans

by Adam Sheldon May 27, 2026June 8, 2026

News in brief: Avecho gains key patent allowances; Montu expands medical affairs team

by Adam Sheldon December 9, 2025February 21, 2026

Cannabis executive salaries: who earned what in FY25

by Adam Sheldon October 22, 2025October 22, 2025